Buy & Sell Alnylam Pharmaceuticals, Inc. (ALNY) – Alnylam Pharmaceuticals, Inc. Price Today
Aura AI Summary
Key Stats
- $41.32BMarket Cap
- HealthSector
- -17.12%3M Drawdown
- $39.69BEnterprise Value
- -Dividend Yield
- 39 daysTypical Hold Time
Alnylam Pharmaceuticals, Inc. (ALNY) is currently valued at a market capitalization of $41.32B, with an enterprise value of $39.69B. Over the past 52 weeks, Alnylam Pharmaceuticals, Inc. has traded between a low of $232.75 and a high of $491.22, highlighting its annual price range. Over the past three months, Alnylam Pharmaceuticals, Inc. has recorded a drawdown of -17.12%, reflecting recent price volatility. On average, investors hold Alnylam Pharmaceuticals, Inc. for approximately 39 days, indicating typical investor behavior on the platform.
About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.
